Capgemini: How AI is Transforming Pharma Drug Discovery | AI Magazine

Pharma companies are spending billions figuring out AI before their competitors do. Sound familiar? Here's what's actually worth paying attention to — and it's not the billion-dollar stuff. You boug

Pharma companies are spending billions figuring out AI before their competitors do. Sound familiar?

Here's what's actually worth paying attention to — and it's not the billion-dollar stuff.

You bought that AI tool. Nobody touched it. Now it sits there at $200/month, a quiet reminder that AI might just not be for your business. That feeling is more common than anyone admits out loud.

Here's what Capgemini's pharma research actually reveals for the rest of us: AI works best when it's dropped into one specific, repetitive process — not spread across an entire operation. Drug researchers didn't overhaul their labs. They picked one bottleneck. That's it.

The lesson translates directly. Your first AI win isn't a platform. It's a single painful task your team does manually, repeatedly, that eats hours every week. Find that one thing first.

Ignore the dashboards, the integrations, the "full AI transformation" pitches. Pick your most boring, time-consuming repeatable task. That's your starting point. No coding, no system overhaul, no consultant required.

Start with a problem, not a product — and ROI becomes measurable fast.

What's the one repetitive task in your business that you'd eliminate tomorrow if you could?

#AIStrategy #SmallBusiness #AIImplementation #BusinessGrowth

Original Source

The integration of AI is no longer a futuristic concept in life sciences. Instead, it is actively rewriting the rules of pharmaceutical R&D. From ...